Market Overview

Akebia Therapeutics (NASDAQ: AKBA)

8.39 -0.31 (-3.56%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2019
After-Hours
EPS:
REV:
-0.46
53.169M



Q2 2019
After-Hours
EPS:
REV:
-0.60
48.793M



Q1 2019
After-Hours
EPS:
REV:
-0.48
45.93M



Q4 2018
After-Hours
EPS:
REV:
0.25
87.316M
-0.24
73.67M


Q3 2018
After-Hours
EPS:
REV:
-0.49
41.283M
-0.64
46.89M
-0.46
53.169M
-28.13%
13.39%
Q2 2018
After-Hours
EPS:
REV:
-0.53
28.52M
-0.51
49.81M
-0.60
48.793M
17.65%
-2.04%
Q1 2018
After-Hours
EPS:
REV:
-1.15
20.865M
-0.59
46.13M
-0.48
45.93M
-18.64%
-0.43%
Q4 2017
After-Hours
EPS:
REV:
-0.99
1.535M
-0.35
48.56M
0.25
87.316M
-171.43%
79.81%
Q3 2017
After-Hours
EPS:
REV:
-0.96
-0.51
37.05M
-0.49
41.283M
-3.92%
11.43%
Q2 2017
After-Hours
EPS:
REV:
-0.95

-0.53
28.52M

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!